EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients

Pierre-Antoine Michel, Karine Dahan, Pierre-Yves Ancel, Emmanuelle Plaisier, Rachid Mojaat, Sophie De Seigneux, Eric Daugas, Marie Matignon, Laurent Mesnard, Alexandre Karras, Hélène François, Agathe Pardon und 3 weitere

Nephron Extra · 2011

DOI: 10.1159/000333068 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephron Extra, 2011. Verfasst von Pierre-Antoine Michel und 14 weiteren Autor:innen. Beteiligte Einrichtung: Service de Néphrologie et Dialyses, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, France. Die Arbeit wurde bisher 22-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of well-tolerated and effective therapies that target the pathogenesis of membranous nephropathy (MN) would be useful. Our objective was to evaluate the efficacy of rituximab in MN. We analyzed the outcome of 28 patients treated with rituximab for idiopathic MN. Anti-PLA2R antibodies in serum and PLA2R antigen in kidney biopsy were assessed in 10 and 9 patients, respectively. Proteinuria was significantly decreased by 56, 62 and 87% at 3, 6 and 12 months, respectively. At 6 months, 2 patients achieved complete remission (CR) and 12 partial remission (PR; overall renal response, 50%). At 12 months (n = 23), CR was achieved in 6 patients and PR in 13 patients (overall renal response, 82.6%). Three patients suffered a relapse of nephrotic proteinuria 27–50 months after treatment. Univariate analysis suggested that the degree of renal failure (MDRD estimated glomerular filtration rate

Schlagwörter

Stichwörter der Autor:innen

Membranous nephropathyProteinuriaRenal failureRituximab

Autor:innen und Institutionen

  • Service de Néphrologie et Dialyses, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, France.

Zitieren

APA

Michel, P. A., Dahan, K., Ancel, P. Y., Plaisier, E., Mojaat, R., De Seigneux, S., Daugas, E., Matignon, M., Mesnard, L., Karras, A., François, H., Pardon, A., Caudwell, V., Debiec, H., & Ronco, P. (2011). Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients. Nephron Extra. https://doi.org/10.1159/000333068

Vancouver

Michel PA, Dahan K, Ancel PY, Plaisier E, Mojaat R, De Seigneux S, et al. Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients. Nephron Extra. 2011. doi:10.1159/000333068

BibTeX
@article{Michel2011,
  author = {Michel, Pierre-Antoine and Dahan, Karine and Ancel, Pierre-Yves and Plaisier, Emmanuelle and Mojaat, Rachid and De Seigneux, Sophie and Daugas, Eric and Matignon, Marie and Mesnard, Laurent and Karras, Alexandre and François, Hélène and Pardon, Agathe and Caudwell, Valérie and Debiec, Hanna and Ronco, Pierre},
  title = {Rituximab Treatment for Membranous Nephropathy: A French Clinical and Serological Retrospective Study of 28 Patients},
  journal = {Nephron Extra},
  year = {2011},
  doi = {10.1159/000333068}
}
Kostenlos starten →